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Harold Aaron Kahn was one of those manyunsung heroes
of the post-World War II movement in epidemiology and
public health around the world. He played key roles in many
of the early epidemiologic cohort studies important to res-
olution of the diet-heart hypothesis, produced a key mono-
graph on the risks of smoking and health (1), and founded
the Framingham Eye Study. However, most of all, he was an
outstanding teacher, whether it was in the classroom,
one-on-one, or as the author of one of the groundbreaking
textbooks in statistical methods in epidemiology.
Harold Kahn, or Hal as he was known to friends and col-
leagues, was born on January 4, 1920, in New York City. He
graduated from high school at the age of 15 and then was
admitted to the prestigious College of the City of New York,
which offeredfreetuitiontoall admitted.Therehecompleted
a Bachelor of Science degree in biology in 1939. In 1940, he
married Lenora Polsky—the love of his life—and their
romance lasted for 67 years, until Lenora’s death in 2006.
After taking the civil service examination, he was as-
signed a job as a surveyor, working on the construction of
the Pentagon. During World War II, he served as a statisti-
cian in the US Public Health Service, with responsibility for
studying venereal disease prevalence and trends. His ﬁrst 4
publications were devoted to the study of syphilis. At the
same time, he continued to study at night, earning a master’s
degree in statistics from American University in 1949 and
completing all but a language requirement that would have
earned him a Ph.D. Most of his career was then spent in the
US Public Health Service.
During his distinguished career, Hal was involved with
a number of the most famous prospective studies of the 20th
century. In 1950, he joined the newly formed National Heart
Institute. After completing several other assignments, he
returned to the National Heart Institute in 1961, where he
served as the Director of Statistics for the Framingham
Heart Study in the mid-1960s. It was while working on
the Framingham Study that he wrote one of his most in-
ﬂuential papers: In 1966, he and Dr. Thomas Dawber pub-
lished a paper in which they proposed what has come to be
known as the ‘‘Framingham method’’ (2). In that method, all
of the risk factor data collected at each of the 2-year study
examinations are entered into a pooled repeated-measures
model to assess the risk of disease within each 2-year period
(3). That is, rather than simply looking at cumulative in-
cidence to date, Hal ‘‘used as the dependent variable the
risk of disease during a 2-year period’’ (4, p. 62). The
1530 Am J Epidemiol 2009;170:1530–1532procedure, which assumes that each 2-year examination is
independent of subsequent ones, has been shown to be
equivalent to the Cox proportional hazards model with
time-dependent covariates, and it continues to be used to
this day (5).
Hal was also part of the group at the National Heart,
Lung, and Blood Institute that helped set up the Puerto Rico
Heart Health Study. However, 2 cardiovascular prospective
studies that he played a key role in were the Yugoslavia
Cardiovascular Heart Disease Study (6) and the Israel
Ischemic Heart Disease Study (7). For 3 years (1966–
1969), he lived in Israel, where his efforts were crucial to
the development and success of the Israel Ischemic Heart
Disease Study. When Hal arrived, he immediately took over
a very complex procedure of editing the detailed dietary
intake questionnaire data, as well as other parameters (8).
Almost overnight, or so it seemed, we were talking about
multiple linear regression and analysis of variance and co-
variance. The next step was introduction of the logistic risk
function, as initially proposed by Cornﬁeld et al. (9), for
estimation of mutually adjusted predictive ability estimates
of the probability of developing a disease according to risk
factors. Kahn was a pioneer, a fresh breeze in what at times
had threatened to become a statistical desert. Consultations
were frequent, and Hal’s teaching ability stood out immedi-
ately. Everyone was impressed by his patience and dedica-
tion. The youngest members of the study coordinating
center found themselves gaining knowledge and insight.
With the backing of William Zukel, the National Heart,
Lung, and Blood Institute Project Ofﬁcer, even the most
menial data clean-up task was converted from a burden to
tolerate into something to look forward to, because there
was so much to learn and develop.
Hal then went on to become chief of the Ofﬁce of
Biometry and Epidemiology for the National Eye Institute
during 1971–1975. It was here that he broke new ground
once again and developed the Framingham Eye Study (10).
After retiring from the US government, he taught at Johns
Hopkins University, where he became a tenured professor of
epidemiology. Upon his retirement from Hopkins, he served
as a consultant and visiting professor at Hebrew University
and at Loma Linda University in California (11), and then
went back to Hopkins. Among other projects, he created an
epidemiologic research unit in Rome for Merck Sharp &
Dohme. Late in life he returned to his interest in dietary
survey methods, and he became involved in promoting the
importance of developing biomarkers for validating ques-
tionnaire methods (12).
In 1983, he published the ﬁrst edition of what was one of
the ﬁrst books on statistical methods in epidemiology (13).
It was intended as an introductory text for students with very
little experience in mathematics, much less statistics. The
focus of the book then and in its second edition was to teach
basic principles so that students could understand the de-
velopment of different statistical methods and the reasons
and rationale for their use in certain situations. The textbook
was revised under a new title in 1989 (14).
Hal was a member of a group of distinguished statisti-
cians that included Jerry Cornﬁeld, Nathan Mantel, Paul
Meier, Olli Miettinen, and others. Norman Breslow must
have had this group in mind when he noted that ‘‘some of
the most important statistical procedures were developed
originally by practitioners on an empirical or intuitive ba-
sis,’’ only to be proven correct by theoreticians a few years
later (15, p. 77). The example Dr. Breslow speciﬁcally men-
tions is Hal’s development of the ‘‘Framingham’’ repeated-
measures analysis technique.
Not only was Hal an outstanding statistician; he instantly
understood the ideas ofCornﬁeld,Mantel, and Miettinen,and
he knew how to teach and communicate those ideas in ways
that were unique. That is why his textbook was so inﬂuential
and popular (13, 14). He could also be exceptionally insight-
ful, as when he developed the Framingham method for the
analysisofrepeatedexaminationdata.Hewasalsoageniusat
getting studies going—whether the Israel Ischemic Heart
Disease Study, the Yugoslavia Cardiovascular Heart Disease
Study, or the Framingham Eye Study.
Hal’s personality made him a born leader. He was char-
ismatic,warm,friendly,andapproachable,yet he hada pres-
ence that commanded respect. He came alive almost like a
vaudeville actor at times—like Al Jolson or Eddie
Cantor—when he was in charge of a project or teaching.
He encouraged thoughtful discussion and debate. However,
disagreeing with him alwaysmadeyou work 3times as hard,
because you never wanted to disappoint him with sloppy or
poorly-thought-out arguments. At just the right moment, he
was able to lighten a discussion with a story or a joke; yet
at other times, he was so very shy and withdrawn.
We believe that Hal’s greatest skills were in leading and
in teaching. His work with the Framingham Study, in
Israel, at the Eye Institute, and in writing the textbook
are great examples of his brilliance as a leader and teacher.
He contributed, in a selﬂess way, so very much to public
health around the world. We both feel that that our lives
and our careers proﬁted greatly by our associations with
Hal. Hal was a kind, wonderful man whom we both feel
privileged to have had the opportunity to work with and to
call a friend.
Harold A. Kahn died at the age of 89 on Thursday, April
9, 2009.
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